Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 7/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.40 |
| ▸ | MAOB | P27338 | 9/20 | 0.38 |
| ▸ | GRM5 | P41594 | 2/20 | 0.38 |
| ▸ | FABP6 | P51161 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20205674 | 0.87 | KDM4E (0.62) | KDM4EALDH1A1L3MBTL1FABP6TDP1 | |
| SCHEMBL30411155 | 0.83 | KDM4E (0.48) | KDM4EALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL15716874 | 0.83 | KDM4E (0.48) | KDM4EALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL19913024 | 0.83 | KDM4E (0.48) | KDM4EALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL15716872 | 0.83 | KDM4E (0.48) | KDM4EALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL20205842 | 0.76 | MAPT (0.46) | KDM4EALDH1A1ESR1ESR2MAOB | |
| SCHEMBL20205837 | 0.75 | ITGB2 (0.43) | KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL20457145 | 0.75 | ITGB2 (0.43) | KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL30563640 | 0.74 | KDM4E (0.38) | KDM4EALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL26962682 | 0.74 | KDM4E (0.38) | KDM4EALDH1A1L3MBTL1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3544973-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO (JP) | 2021-07-28 | — | — | EP | disclosed |
| WO-2018097318-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | CYC1, MT-CO1, CTRL | KDM4E 3773/4885ALDH1A1 1744/4885L3MBTL1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.